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ABSTRACT
While the prevalence of shortness of breath has been reported to be as frequent as pain in people with lung cancer, less
attention has been paid to the distress associated with this symptom (dyspnea). This systematic review of the literature was
undertaken to investigate how this symptom has been assessed and whether breathlessness in people with lung cancer is
distressing. Using a pre-determined
determined search strategy and inclusion criteria, thirty
thirty-one primary studies were identified and included
in this review. A variety of outcome measures have been used to assess the experience of dyspnea with domains including
intensity, distress, quality of life, qualitative sensation and prevalence. The distress associated with breathl
breathlessness
essness appears to be
variable, with some studies reporting it to be the most distressing sensation, while others report lower levels of distress. Overall
the studies reflect a high prevalence of dyspnea in lung cancer patients, with subjects experiencing a moderate level of dyspnea
intensity and interference with activities of daily living. Overall, the findings of this review indicate that dyspnea was a common
symptom experienced by people with lung cancer with varying degrees of intensity and unpleasantn
unpleasantness.
ess. Thus, if dyspnea and
pain are both distressing sensations for people with lung cancer, this has potential implications for both clinical and acade
academic
areas, with regards to both management strategies and further research.
BACKGROUND
There are currently in excess of 1.3 million people worldwide affected by lung cancer. 1 Lung cancer is the leading cause of
cancer death in the United States, with an estimated 565,650 people dying from lung cancers in 2008. 2 Up to ninety percent of
lung cancer
ancer is related to active cigarette smoking, with the remaining ten percent mainly caused by passive smoking and
exposure to medical radiation and environmental factors such asbestos and silica
silica.1 People with lung cancer experience
symptoms which vary between individuals, resulting in a range of symptoms which people might find distressing. 3 There are
several common signs and symptoms associated with lung cancer, which can be classified as a result of the primary tumour,
intra-thoracic spread, distant metastases,
etastases, paraneoplastic syndromes or they may be non
non-specific symptoms. 3 The most common
signs and symptoms relating to a primary lung tumour, and therefore corresponding to early stage disease, are: cough, dyspnea
(distress with breathing or breathing discomfort) haemoptysis (coughing up blood) and chest discomfort. Non
Non-specific
specific symptoms
such as weight-loss
loss or fatigue are also common in the initial stages of lung cancer. 3
Pain and dyspnea have been reported to be common distressing symptoms in people with cancer. Beckles et al (2003) report
that while 6 to 25% of people with lung cancer will experience bone pain and 20 to 49% will experience chest pain, somewhere
between 3 and 60% will experience dyspnea.3 While the incidence of dyspnea in people with lung cancer has been reported to
be at least as frequent as pain, its presence is underappreciated and potentially not scrutinized or investigated to the same
extent.4 For example, a preliminary search of the database Scopus reveals almost twice as much literature
terature addressing pain and
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pain management in people with lung cancer, compared with that of dyspnea. The purpose of this paper is to systematically
review primary studies of people with lung cancer in order to answer two specific questions:
1.
2.

Which outcome measures have been used to assess breathlessness?
What evidence is there that breathlessness is distressing?

SYSTEMATIC SEARCH STRATEGY
A systematic search process was undertaken to identify peer reviewed publications specifically investigating the sensation of
breathlessness in people with lung cancer. When developing the review question, the PICO structure was used. PICO is an
acronym for population, interventions, comparisons and outcomes. 5 The population of interest was adults with lung cancer, of
any type or stage. Studies were limited to observation or epidemiological studies. As the intent of the systematic review was not
to explore the evidence for management strategies for breathlessness, no intervention or comparator was specified for this
question. The outcome of interest was data on the sensation of dyspnea or breathlessness. Three groups of search terms were
identified. The first group of search terms included lung cancer and lung neoplasms, the second: dyspnea and breathlessness;
and third: distress, perception and sensation. Each term within a group was separated by “or” and each group was separated by
“and”. The database search was undertaken between late February and early March 2008. The databases (Ovid) Medline and
Embase, Cochrane Library, CINAHL, PsycINFO and Scopus were searched using the default settings except in Ovid, where
‘advanced search’ was used. Table 1 presents the citations retrieved using the search strategy, and those which were retained in
each database.
______________________________________________________________________________________________________
Table 1: Retrieved and retained citations in each database
Database
Date of Search
Retrieved citations
Retained citations
MEDLINE
26/02/08
339
2
EMBASE
26/02/08
418
8
Cochrane Library
26/02/08
137
0
CINAHL
28/02/08
186
13
PsycINFO
28/02/08
174
2
Scopus
02/03/08
391
6
______________________________________________________________________________________________________
During the first wave of the search, citations were retained if they met the following five criteria:
1.
2.
3.
4.
5.

Must refer to distress/perception/sensation of dyspnea/breathlessness or symptoms, rather than psychological distress
in the abstract or title
Must not refer to any drugs for the treatment of breathlessness/dyspnea
Subjects: must include lung cancer
Language of publication: English
Publication: peer reviewed journal article (no grey literature)

The search identified 143 articles where the title met the inclusion criteria. When information in the abstract for each citation was
reviewed, 36 citations were excluded as they did not meet the inclusion criteria. Full text versions of citations were retrieved for
the remaining 107 articles meeting the inclusion criteria or where abstracts were ambiguous and could not be confidently
excluded from the review. Upon retrieval of the full versions, articles were included within the systematic review if they met the
following four criteria (second wave of review):
1.
2.
3.
4.

Must meet the above five criteria on review of the full-text article
Must not be a study investigating an intervention for the management of breathlessness (except cohort studies which
included an intervention as part of the normal treatment (e.g. surgery, chemotherapy or radiotherapy) and were not
compared to a control group (i.e. not explicitly an intervention study)
Report original primary, data (continuous ratio, categorical, nominal scales or text) on the presence of dyspnea
(intensity/qualitative sensation /severity/associated distress)
Data specific to people with lung cancer data must be able to be extracted

Thirty-one articles were retained which satisfied the above criteria. Table 2 details each of the studies included in the review in
terms of research design, sample size and stage of cancer.
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Table 2: Characteristics of the articles retained in the second wave of the search strategy
Research design
Sample size
Lung cancer stage
(n = )
Tishelman et al 20076
Longitudinal
400
I-IV
Broberger et al 20077
Longitudinal
46
Not reported
Henoch et al 20078
Longitudinal
105
Not reported
Hirakawa et al 20069
Observational
33 (26%)
Not reported
Tanaka et al 2002a10
Observational
157
IIIA-IV and recurrent
Heedman and Strang 200111
Longitudinal
60 (14%)
Not reported
Smith et al 200112
Observational
120
I-IV
Hopwood and Stephens 199513
Observational
819
Not reported
Sarna 199314
Observational
69
Not reported
Brown et al 198615
Longitudinal
30
Limited + extensive disease + stage III
Lai et al 200716
Qualitative descriptive 11
IIIB and IV
Broberger et al 200517
Longitudinal
85
Not reported
Oh 200418
Cross-sectional
106
I-IV
Kuo and Ma 200219
Descriptive correlation 73
Majority stage IV, others not reported
Tanaka et al 2002b20
Observational
171
III, IV or recurrent stage
Tanaka et al 2002c21
Observational
171
III, IV or recurrent stage
Kurtz et al 200222
Longitudinal
228
Early and late stage disease
Lutz et al 200123
Observational
69
IV, extensive stage, locally recurrent
Tishelman et al 200024
Longitudinal
26
Not reported
Kurtz et al 200025
Cross-sectional
129
Early and late stage disease
O’Driscoll et al 199926
Prospective RCT
52
Not reported
Lobchuk et al 199727
Observational
41
Limited and extensive disease, stages I-IV
Sarna and Brecht 199728
Observational
60
Advanced stage
Sarna 199529
Observational
65
Not reported
McCorkle and Quint-Benoliel
Longitudinal
67
Not reported
198330
Chan et al 200531
Longitudinal
27
Advanced stage
Clayson et al 200532
Qualitative
15
Not reported
Tishelman et al 200533
Longitudinal
400
I-IV
Akechi et al 200234
Longitudinal
129
III-IV
Dudgeon et al 200135
Observational
37 (4%)
Not reported
Langendijk et al 200036
Observational
262
I-IV
RCT = Randomised Controlled Trial
I, II, III(B), IV = Cancer stages 1, 2, 3(B), 4
______________________________________________________________________________________________________
APPRAISAL OF POTENTIAL BIAS
Each article was appraised for potential bias using a four point checklist devised especially for use in this review. Four key points
were identified which could potentially affect the believability of the dyspnea data:
Article

1.
2.
3.
4.

Subjects needed to have a definite diagnosis of lung cancer
Reliability and validity needed to be reported or cited for the dyspnea outcome measure
The assessment method needed to be described adequately to permit repeatability
The data needed to represent the lung cancer patients (i.e. minimal missing data)

Table 3 presents the results of the appraisal process. A shaded cell indicates the study fulfilled the criterion whereas an unshaded cell indicates it was unclear from the detail provided in the study as to whether the criterion was satisfied. Only nine of
the 31 articles satisfied the four criteria. All of the studies met the first criteria of a diagnosis of lung cancer. Twenty-four articles
reported the reliability and validity of the instrument used to assess dyspnea and seventeen studies reported a complete or near
complete data set. Large amounts of missing data have the potential to bias the study’s results and influence the believability of
the data. The least satisfied criterion occurred in the description of the assessment method; with only sixteen studies providing
sufficient detail to allow for replication. Thus bias potentially exists for the reliability and validity of assessment tools for dyspnea

© The Internet Journal of Allied Health Sciences and Practice, 2009

Distress with Breathing in People with Lung Cancer: A Systematic Review

4

and for the replicabililty of the studies. A single study satisfied only one criterion, with the majority of studies satisfying all or most
of the criteria. Therefore confidence can be placed to some extent in the accuracy of the believability of the dyspnea data.
______________________________________________________________________________________________________
Table 3: Appraisal of potential bias within studies (n=31).
Article
Lung cancer
Tool
Method
Data
Tishelman et al 20076
Broberger et al 20077
Henoch et al 20078
Hirakawa et al 20069
Tanaka et al 2002a10
Heedman and Strang 200111
Smith et al 200112
Hopwood and Stephens 199513
Sarna 199314
Brown et al 198615
Lai et al 200716
Broberger et al 200517
Oh 200418
Kuo and Ma 200219
Tanaka et al 2002b20
Tanaka et al 2002c21
Kurtz et al 200222
Lutz et al 200123
Tishelman et al 200024
Kurtz et al 200025
O’Driscoll et al 199926
Lobchuk et al 199727
Sarna and Brecht 199728
Sarna 199529
McCorkle and Quint-Benoliel
198330
Chan et al 200531
Clayson et al 200532
Tishelman et al 200533
Akechi et al 200234
Dudgeon et al 200135
Langendijk et al 200036
Grey: satisfied criterion, White: unclear if criterion satisfied
______________________________________________________________________________________________________
OUTCOME MEASURES FOR BREATHLESSNESS
Eighteen separate outcome measures were used to assess breathlessness in the 31 studies (Table 4). Studies using different
types of questionnaires and interviews were grouped under the collective terms of ‘questionnaire’ or ‘interview’. Several
composite outcome measures included a number of different discrete outcome measures. For example the Edmonton Symptom
Assessment Scale (ESAS) consists of nine separate Visual Analogue Scales (VAS). Table 4 presents the outcome measures
used to assess the sensation of breathlessness
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Table 4: Outcome measures for the sensation of breathlessness within the studies retained for the review
AQEL18

GBS17

LCSS16

VRS15

DNS14

SES13

I12

Q11

DAG10

RSCL9

SDS8

VAS7

CDS6

FL5

TSSD4

LC133

C302

ESAS1

Article
Tishelman et al 20076
Broberger et al 20077

Henoch et al 20078
Hirakawa et al 20069
Tanaka et al 2002a10
Heedman and Strang 200111
Smith et al 200112
Hopwood and Stephens 199513
Sarna 199314
Brown et al 198615
Lai et al 200716
Broberger et al 200517
Oh 200418
Kuo and Ma 200219
Tanaka et al 2002b20
Tanaka et al 2002c21
Kurtz et al 200222
Lutz et al 200123
Tishelman et al 200024
Kurtz et al 200025
O’Driscoll et al 199926
Lobchuk et al 199727
Sarna and Brecht 199728
Sarna 199529
McCorkle and Quint-Benoliel
198330
Chan et al 200531
Clayson et al 200532
Tishelman et al 200533
Akechi et al 200234
Dudgeon et al 200135
Langendijk et al 200036
1Edmonton Symptom Assessment Scale, 2EORTC-QLQ-C30, 3EORTC-QLQ-LC13, 4Thurstone Scale of Symptom Distress,
5Free-listing, 6Cancer Dyspnea Scale, 7Visual Analogue Scale, 8Symptom Distress Scale, 9Rotterdam Symptom Checklist,
10Dyspnea Assessment Guide, 11Questionnaire, 12Interview, 13Symptom Experience Scale, 14Dypnea Numerical Scale, 15Verbal
Rating Scale for Dyspnea, 16Lung Cancer Symptom Scale, 17Grade of Breathlessness Scale, 18Assessment of Quality of Life at
the End of Life
______________________________________________________________________________________________________
DEGREE OF DISTRESS ASSOCIATED WITH THE SENSATION OF BREATHLESSNESS IN PEOPLE WITH LUNG CANCER
The following section collates and reports the degree of distress with the sensation of breathlessness in people with lung cancer.
The eighteen dyspnea outcome measures were grouped into similar domains. Table 5 presents the five domains for dyspnea
assessment, and the outcome measures which fall under each category. Several outcome measures are listed in two or more
domains as they satisfy multiple criteria. However outcomes were also listed in several or alternate columns to which they were
originally intended. For example, the VAS and VRS have the ability to measure the intensity of dyspnea, however as the intensity
wasn’t reported in the study, data was only able to be extracted on the presence of dyspnea and thus was classified under an
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alternate heading for which it was originally designed. 35 Whether the data obtained from studies using a longitudinal design is
based on baseline measures or averaged over several time periods is also reported.
______________________________________________________________________________________________________
Table 5: Outcome measures categorized according to the mode of dyspnea assessment
Domain
Outcome measure
Symptom intensity
Visual Analogue Scale (VAS), Edmonton Symptom Assessment Scale (ESAS), Dyspnea Numerical
Scale (DNS), Grade of Breathlessness Scale (GBS), European Organization for the Research and
Treatment of Cancer questionnaire (EORTC-QLQ-C30 and EORTC-QLQ-LC13), Assessment of
Quality of Life at the End of Life questionnaire (AQEL)
Quality of life
Questionnaires
Symptom distress

Thurstone Scale of Symptom Distress (TSSD), Cancer Dyspnea Scale (CDS), Symptom Distress
Scale (SDS), Free-listing

Symptom prevalence

Lung Cancer Symptom Scale (LCSS), Questionnaire, Symptom Experience Scale (SES), Rotterdam
Symptom Checklist (RSCL), Verbal Rating Scale for Dyspnea (VRS), VAS, Interview, Dyspnea
Assessment Guide (DAG)

Interview

Interview, Free-listing

Symptom Intensity
Visual analogue scales (VAS). Four studies assessed resting dyspnea using a visual analogue scale (VAS) anchored with ‘no
dyspnea’ to ‘maximum dyspnea’. The mean VAS data in each study was 39.54, 73.3, 8.44 and 45.0 (Brown et al 1986, Lai et al
2007, Chan et al 2005, Heedman and Strang 2001 respectively). Overall the mean VAS across studies was 41.6mm. Overall this
indicates a moderate intensity of dyspnea; however the individual VAS results for the four studies convey markedly varied
reports of dyspnea intensity (i.e. ranging from very low (8.44mm), to quite high (73.3mm)).
Dyspnea Numerical Scale (DNS). Using the DNS, both Tanaka et al (2002a and 2002c) reported a median DNS score to be 2
out of 10 (range 0-9). Tanaka et al (2002c) reported the mean DNS score to be 2.2 out of 10, while the mean score was not
reported for Tanaka et al (2002a). Overall this indicates a low intensity of dyspnea.
Grade of Breathlessness Scale (GBS). Using the GBS, Brown et al (1986) reported the mean dyspnea score to be 3.64 on a 0
(no shortness of breath) to 5 (too breathless to leave the house) scale (baseline measure). This indicates a moderate-high
intensity of dyspnea.
European Organization for the Research and Treatment of Cancer questionnaire (EORTC-QLQ-C30, EORTC-QLQ-LC13),
Assessment of Quality of Life at the End of Life questionnaire (AQEL). These three outcome measures assess quality of life
via questionnaires; however they have been included in the ‘symptom intensity’ section as the breathlessness components of the
quality of life questionnaires by themselves do not convey quality of life. The average dyspnea score for the three studies,
assessed using the EORTC-QLQ-C30 and LC13 was 46 (0-100 scale), where a higher score indicates a greater degree of
symptoms (and a likely poorer quality of life). These results signify moderate degree of dyspnea (Table 6).Henoch et al 2007
used the AQEL to assess quality of life at the end of life. Individual dyspnea scores were reported to be 8.5 (1-10 scale)
(averaged over 5 time periods), whereby higher scores indicate less symptom burden. This indicates a rather low dyspnea
burden.
______________________________________________________________________________________________________
Table 6: Individual dyspnea scores as assessed by the EORTC-QLQ-C30 and LC13
Mean Dyspnea score (0-100)
EORTC-QLQ-C30
EORTC-QLQ- LC13

Tishelman et al
20076
53 (average 6
time periods)

Broberger et al 20077

Langendijk et al 200036

63 (average 3 time periods)

38 (average 3 groups, C30
and LC13 not differentiated
between)

39 (average 6
time periods)

39 (average 3 time periods)

AQEL
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Quality of life
Questionnaires: Tanaka et al (2002a and 2002c) used ‘interference’ questionnaires to investigate the impact of dyspnea on
activities of daily living. Tanaka et al (2002a) reported that 52 percent (n = 81) of subject’s dyspnea interfered with any physical
domain, while 23 percent (n = 36) interfered with any psychological domain. Tanaka et al (2002c) reported that dyspnea
interfered with at least one daily life activity in 55 percent of patients (n = 94).
Symptom Distress
Thurstone Scale of Symptom Distress (TSSD). Interestingly, of the four studies assessing distress associated with dyspnea
using the TSSD, the majority report dyspnea to be ranked as the number one distress-causing symptom in lung cancer (Table 8).
Tishelman et al 2007 (in all 6 time periods), Broberger et al 2005 (average over several time periods) and Tishelman et al 2005
(baseline) all reported dyspnea to have a TSSD ranking of one, while Tishelman et al 2000 (baseline) reported dyspnea to have
a TSSD ranking of two.
Cancer Dyspnea Scale (CDS). Three studies used the multidimensional CDS to assess dyspnea, with two reporting median
values (Tanaka et al 2002a and 2002b) and two reporting mean values (Tanaka et al 2002b and Henoch et al 2007). The
combined average total dyspnea score was 7 (out of 48), with median 7, indicating a less severe dyspnea experience. Henoch et
al 2007 (baseline measure) reported a mean CDS score of 5.80, while Tanaka e al 2002b reported a mean score of 8 and
median score of 7. Similarly, Tanaka et al 2002a reported at median CDS score of 7.

Tishelman et
al 200533

McCorkle and
Quint-Benoliel
198330

Sarna 199529

Sarna and
Brecht 199728

Lobchuk et al
199727

Tishelman et
al 200024

Kuo and Ma
200219

Oh 200418

Broberger et
al 200517

SDS
score

Sarna et al
199314

Symptom Distress Scale (SDS). The ten studies using the SDS to assess distress associated with dyspnea reveal a combined
average score of 2.1 out of 5 (Table 7). This indicates a moderate level of distress associated with dyspnea overall.
______________________________________________________________________________________________________
Table 7: Individual SDS scores

1.9
2.2#
2.48
0.81
2.31*
2.22
1.80
1.78
1.88*
3.6*
#
*baseline measure, averaged over several time periods
______________________________________________________________________________________________________
Using the SDS, four of the ten studies specified a rank for dyspnea with the average being seven, on a scale of 1 to 13 (Sarna et
al 1993: Rank 8, Broberger et al 2005: Rank 7 (averaged over several time periods), Lobchuk et al 1997: Rank 5.5 and Sarna
and Brecht: Rank 7).
Free-Listing (FL) Free-Listing is a structured approach allowing identification of relevant issues without imposing researchers’
assumptions and was used in order to ascertain the patient’s most distressing symptoms. 7 Patients most frequently reported
fatigue, pain and dyspnea as those concerns causing them the most distress at both baseline and 6 months follow-up. 7
Symptom Prevalence
A variety of outcomes were used to report on the prevalence of dyspnea. Table 8 presents the percentage of subjects within
each study reported the presence of dyspnea. The average prevalence reported by studies included in this review was 70.5
percent, with a range of 50 to 87 percent. This indicates a high prevalence of dyspnea (Table 8).
______________________________________________________________________________________________________
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LCSS

Lutz et al 200123
Hirakawa et al 20069
Kurtz et al 200222

73 (60)

8

Table 8: Dyspnea prevalence
% of subjects (n=)
Questionnaire
SES
VAS and
Interview
VRS

RSCL

DAG

82 (27)
56
(228)*
61 (79)

Kurtz et al 200025
Chan et al 200531
59 (27)*
Dudgeon et al 200135
84 (37)
Clayson et al 200532
50 (7)
Akechi et al 200234
66 (59) ¤
Hopwood and Stephens
87 (819)
199513
Smith et al 200112
87 (115)
*Baseline measure, #estimated from graph, ¤averaged over several time periods
______________________________________________________________________________________________________
Interview
The studies which included interviews as an outcome measure assessed many different aspects of dyspnea. These included: the
physical and emotional sensations (language) of dyspnea, thoughts, feelings and experiences with dyspnea, causes of dyspnea,
the effect of dyspnea on the person’s life and their management of dyspnea. While it was not the primary purpose these studies,
Brown et al (1986), O’Driscoll et al (1999), Clayson et al (2005), Lai et al (2007), Broberger et al (2007) and Tishelman et al
(2005) report on the language used to describe dyspnea. All six studies obtain dyspnea descriptors via interviews, using words
volunteered by subjects and /or words selected from a pre-existing list of breathlessness descriptors. Wilcock et al (2002) is the
only study to date which has investigated the language of breathlessness using lung cancer patients, using the ‘endorsed’
descriptor method.37 It should be noted that the Wilcock et al (2002) article was not identified during the systematic search nor
did any of the studies included within the review refer to this study. The volunteered descriptors in Lai et al (2007) and Tishelman
et al (2005), reported below, are not verbatim from the article, but instead have been classified into breathlessness categories by
the review authors. All other studies using volunteered language have taken subject’s descriptors and grouped them into similar
categories in order to report them (some also reporting the original descriptors as well). Table 9 highlights the most commonly
reported dyspnea descriptors in the seven studies.
______________________________________________________________________________________________________
Table 9: Most commonly reported dyspnea descriptors in the seven studies including data on the language of
breathlessness
Brown et al
O’Driscoll et al Clayson et al
Lai et al
Broberger et
Tishelman et
Wilcock et al
198615* (2 time 199926*
200532*
200716*
al 20077 (2
al 200533
200237#
periods)
time periods) (several time
periods)
Short of breath
Shortness of
Fighting for
Labour
Decreased
Frightening
I feel out of
breath
breath
breathing
breath
capacity
Difficulty
Panic
Gasping for air Suffocating
Short of breath Distress
I cannot get
breathing
enough air
Hard to move
Feeling of
Tight
air
impending
death
Tired or
Fear/fright
Can’t breathe
fatigued
Awful
*Volunteered descriptors, #Endorsed descriptors
______________________________________________________________________________________________________
With the exception of the endorsed descriptors in Wilcock et al’s (2002) study which do not have an affective component, four out
of the six studies on language report both physical and affective terms to describe dyspnea. 37 The physical descriptors
conveying ‘shortness of breath’, ‘difficulty breathing’ and/or ‘labour’ type words are common to most studies. With the exception
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of ‘frightening’, the affective terms used to describe dyspnea differ between studies; however all of the terms indicate
considerable distress associated with the sensation of dyspnea. Inaccurate categorizing, generalisation when reporting the data
and differences in sample size and research design may account for differences between the terms used to describe dyspnea in
the above studies.
DEGREE OF DISTRESS ASSOCIATED WITH THE SENSATION OF BREATHLESSNESS IN PEOPLE WITH LUNG CANCER
(ANALYSED ACCORDING TO STAGE).
The studies included within this systematic review fall into two groups: those reporting on all stages of lung cancer (I-IV), or those
only reporting on advanced stage lung cancer (III, IV or extensive disease). The studies were further analysed to determine
whether any relationship existed between the stage of lung cancer, and the level of distress associated with dyspnea. Table 10
outlines the studies including subjects with all types of lung cancer, and the corresponding degree of dyspnea unpleasantness;
low, moderate or high as reported in previous sections. Table 11 outlines the studies including only subjects with late stage lung
cancer, and the subsequent degree of dyspnea unpleasantness.
______________________________________________________________________________________________________
Table 10: Degree of unpleasantness with dyspnea in studies including subjects with all stages of lung cancer
Article

Data group

Outcome measure

Tishelman et al 20076

Intensity, Distress

EORTC-C30 and LC13
and TSSD

Data

Degree of
unpleasantness
Moderate

C30 = 53
LC13 = 39
TSSD =1
Smith et al 200112
Prevalence
DAG
87% (n = 115)
High
Oh 200418
Distress
SDS
2.48
Moderate
Kurtz et al 200222
Prevalence
SES
56% (n = 228)
Moderate
Kurtz et al 200025
Prevalence
SES
61% (n = 79)
High
Lobchuk et al 199727
Distress
SDS
2.22
Moderate
Tishelman et al 200533
Distress, Interview
TSSD, SDS, volunteered TSSD = 1
High
language
SDS = 3.6 Frightening,
distress
Langendijk et al 200036
Intensity
EORTC-C30 and LC13
C30 + LC13 = 38
Moderate
__________________________________________________________________________________________________________________

Table 11: Degree of unpleasantness with dyspnea in studies including subjects with late stage lung cancer

Article

Data group

Outcome measure(s)

Data

Tanaka et al 2002a10

Intensity, distress,
quality of life

DNS, CDS, Q

Brown et al 198615

Intensity, Interview

VAS, GBS,
volunteered language

Lai et al 200716

Intensity, Interview

VAS, volunteered
language

Kuo and Ma 200219
Tanaka et al 2002b20
Tanaka et al 2002c21

Distress
Distress
Intensity, Quality of Life

SDS
CDS
DNS, Q

DNS = 2 (median)
CDS = 7 (median)
Q = 52% (n = 81)
VAS = 39.54
GBS = 3.64
Short of breath
Difficulty breathing
Hard to move air
Tired or fatigued
VAS = 73.3
Labour
Suffocating
Tight
Can’t breathe
Awful
0.81
7 (median)
DNS = 2 (median)
Q = 55% (n = 94)

Lutz et al 200123
Sarna and Brecht 199728
Chan et al 200531
Akechi et al 200234

Prevalence
Distress
Intensity
Prevalence

LCSS
SDS
VAS
I

73% (n = 60)
1.80
8.44
66% (n = 59)

Degree of
unpleasantness
Low to moderate
Moderate

High

Low
Low
Low to moderate
High
Low
Low
High

______________________________________________________________________________________________________
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From the tables 10 and 11, it can be seen that the studies reporting on subjects with all stages of lung cancer generally had
moderate-high degree of unpleasantness associated with dyspnea. Conversely, the studies reporting on subjects with advanced
lung cancer generally had a larger spread of unpleasantness, ranging from low to high. This suggests that there is no clear
relationship between the stage of cancer and level of distress, contrary to notion that the as the more advanced the lung cancer,
the higher the distress associated with dyspnea becomes.
SUMMARY OF FINDINGS FOR THE SYSTEMATIC REVIEW
It is clear a variety of different outcome measures were used to assess the experience of dyspnea, and that varying results were
obtained, regarding the intensity, prevalence and distress associated with dyspnea. No clear relationship existed between the
stage of lung cancer and the degree of distress associated with breathing. Overall the studies report a high prevalence of
dyspnea in lung cancer patients, with subjects experiencing a moderate level of dyspnea intensity and interference with activities
of daily living. Distress associated with breathing appears to be variable, with some studies reporting dyspnea to be the most
distressing sensation, while others report lower levels of distress. The language used to describe the qualitative sensation of
dyspnea involved both physical and affective words. Physical descriptors conveying ‘shortness of breath’, ‘difficulty breathing’
and/or ‘labour’ type words were common to all studies, however with the exception of ‘frightening’ the affective terms used to
describe dyspnea differ between studies; although all of the affective terms used indicate considerable distress associated with
the sensation of dyspnea. However, taking into account the prevalence, intensity and distress of dyspnea, the general consensus
appears to be that the experience of dyspnea in people with lung cancer is common with varying degrees of intensity, but
involves considerable unpleasantness. Thus if dyspnea and pain are both distressing sensations for people with lung cancer, this
has potential implications for both clinical and academic areas, with regards to both management strategies and further research.
______________________________________________________________________________________________________
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